For instance, earlier in the pandemic we saw funding to househomeless people, provide COVID-related health care to non-English speaking communities, and for people isolated at home. These initiatives need to continue. Other countries have also recognized the need for more equitable access to COVI...
This year in Australia, the XBB COVID strains have dominated, and acquired a couple of key mutations. When COVID mutates into new variants, it doesn't affect the ability of either Paxlovid or Lagevrio to work because the parts of the virus that change from the mutations aren't those ta...
Based on the data reported in Hong Kong for patients with COVID-19 from the end of 2020 to March 2022, the number of deaths and serious illnesses was 6866 and 8875, respectively [21]. Previous data on another antiviral drug, Paxlovid, showed that the placebo group had 65 hospitalizations...
There's no clear answer on whether those eligible for a second booster need to rush out for one.Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, told reporters he would advise older relatives to get another booster right away "because of the...
that a five-day course of PAXLOVID™ presumably costs around $530 (the U.S. governmentpaid $5.3 billion for 10 million coursesof PAXLOVID™ in November 2021), how many billions of dollars has the U.S. government squandered in facilitating the use of this antiviral treatment for COVID-...